Renal nerves in blood pressure regulation

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 5, 2013, Pages 504-510

  Johns, Edward J ^a,b   Abdulla, Mohammed H ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Allianze University College of Medical Sciences   (Malaysia)

Author keywords

afferent renal nerves; hypertension; kidney; renal sympathetic nerves; sympathetic nervous system

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; ELECTROSTIMULATION; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY DENERVATION; KIDNEY NERVE; NEPHRITIS; OSMOTIC PRESSURE; PRIORITY JOURNAL; REVIEW; SYMPATHETIC INNERVATION;

EID: 84882452531     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283641a89     Document Type: Review

References (86)

1. Tsioufis C, Kordalis A, Flessas D, et al. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens 2011; 2011:642416.
2. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54:690-697.
3. Mabin T, Sapoval M, Cabane V, et al. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. Euro Interven 2012; 8:57-61.
4. Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20:933-939.
5. Ye S, Gamburd M, Mozayeni P, et al. A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens 1998; 11:723-728.
6. Iliescu R, Yanes LL, Bell W, et al. Role of the renal nerves in blood pressure in male and female SHR. Am J Physiol Regul Integr Comp Physiol 2006; 290:R341-344.
7. Salgado HC, Barale AR, Castania JA, et al. Baroreflex responses to electrical stimulation of aortic depressor nerve in conscious SHR. Am J Physiol Heart Circ Physiol 2007; 292:H593-600.
8. Schlaich MP, Sobotka PA, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361:932-934.
9. Heusser K, Tank J, Engeli S, et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010; 55:619-626.
10. Krum H, Sobotka P, Mahfoud F, et al. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 2011; 123:209-215.
11. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117:e510-e526.
12. Sarwar MS, Islam MS, Al Baker SM, Hasnat A. Resistant hypertension: underlying causes and treatment. Drug Res (Stuttg) 2013; 63:217-223.
13. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52:1749-1757.
14. Wang Y, Seto SW, Golledge J. Therapeutic effects of renal denervation on renal failure. Curr Neurovasc Res 2013; 10:172-184.
15. Barajas L, Liu L, Powers K. Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Can J Physiol Pharmacol 1992; 70:735-749.
16. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77:75-197.
17. John EJ, Kopp UC, DiBona GF. Neural control of renal function. Comp Physiol 2011; 1:731-767.
18. Zanchetti AS. Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. Circulation 1977; 56:691-698.
19. Keeton TK, Campbell WB. The pharmacologic alteration of renin release. Pharmacol Rev 1980; 32:81-227.
20. Osborn JL, Francisco LL, DiBona GF. Effect of renal nerve stimulation on renal blood flow autoregulation and antinatriuresis during reductions in renal perfusion pressure. Proc Soc Exp Biol Med 1981; 168:77-81.
21. Kirchheim H, Ehmke H, Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr 1989; 67:858-864.
22. DiBona GF, Sawin LL. Effect of renal nerve stimulation on responsiveness of the rat renal vasculature. Am J Physiol Renal Physiol 2002; 283:F1056-F1065.
23. Armenia A, Munavvar AS, Abdullah NA, et al. The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats. Br J Pharmacol 2004; 142:719-726.
24. Abdulla MH, Sattar MA, Salman IM, et al. Effect of acute unilateral renal denervation on renal hemodynamics in spontaneously hypertensive rats. Auton Autacoid Pharmacol 2008; 28:87-94.
25. Sattar MA, Johns EJ. Evidence for an alpha 1-adrenoceptor subtype mediating adrenergic vasoconstriction in Wistar normotensive and stroke-prone spontaneously hypertensive rat kidney. J Cardiovasc Pharmacol 1994; 23:232-239.
26. Esler M, Jennings G, Korner P, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988; 11:3-20.
27. Lundin S, Ricksten SE, Thoren P. Interaction between "mental stress" and baroreceptor reflexes concerning effects on heart rate, mean arterial pressure and renal sympathetic activity in conscious spontaneously hypertensive rats. Acta Physiol Scand 1984; 120:273-281.
28. Robertson WP, Schofield GG. Primary and adaptive changes of A-type K\+ currents in sympathetic neurons from hypertensive rats. Am J Physiol 1999; 276:R1758-1765.
29. Tran LT, MacLeod KM, McNeill JH. Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Mol Cell Biochem 2009; 330:219-228.
30. Shokoji T, Nishiyama A, Fujisawa Y, et al. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 2003; 41:266-273.
31. Morgan DA, Anderson EA, Mark AL. Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 1995; 25:834-838.
32. Suzuki H, Nishizawa M, Ichikawa M, et al. Basal sympathetic nerve activity is enhanced with augmentation of baroreceptor reflex in Wistar fatty rats: a model of obesity-induced NIDDM. J Hypertens 1999; 17:959-964.
33. DiBona GF, Sawin LL. Frequency response of the renal vasculature in congestive heart failure. Circulation 2003; 107:2159-2164.
34. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989; 14:177-183.
35. Jennings GL. Noradrenaline spillover and microneurography measurements in patients with primary hypertension. J Hypertens Suppl 1998; 16:S35-S38.
36. Fujii T, Takaoka M, Muraoka T, et al. Preventive effect of L-carnosine on ischemia/reperfusion-induced acute renal failure in rats. Eur J Pharmacol 2003; 474:261-267.
37. Mi Z, Jackson EK. Effects of alpha-and beta-adrenoceptor blockade on purine secretion induced by sympathetic nerve stimulation in the rat kidney. J Pharmacol Exp Ther 1999; 288:295-301.
38. Katholi RE, Whitlow PL, Hageman GR, Woods WT. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens 1984; 2:349-359.
39. Liu L, Barajas L. The rat renal nerves during development. Anat Embryol (Berl) 1993; 188:345-361.
40. Solano-Flores LP, Rosas-Arellano MP, Ciriello J. Fos induction in central structures after afferent renal nerve stimulation. Brain Res 1997; 753:102-119.
41. Ciriello J, de Oliveira CV. Renal afferents and hypertension. Curr Hypertens Rep 2002; 4:136-142.
42. Gontijo JA, Kopp UC. Activation of renal pelvic chemoreceptors in rats: role of calcitonin gene-related peptide receptors. Acta Physiol Scand 1999; 166:159-165.
43. Gontijo JR, Smith LA, Kopp UC. CGRP activates renal pelvic substance P receptors by retarding substance P metabolism. Hypertension 1999; 33:493-498.
44. Kopp UC, Cicha MZ, Farley DM, et al. Renal substance P-containing neurons and substance P receptors impaired in hypertension. Hypertension 1998; 31:815-822.
45. Kopp UC, Smith LA, DiBona GF. Renorenal reflexes: neural components of ipsilateral and contralateral renal responses. Am J Physiol 1985; 249:F507-517.
46. Smits JF, Brody MJ. Activation of afferent renal nerves by intrarenal bradykinin in conscious rats. Am J Physiol 1984; 247:R1003-R1008.
47. Converse RL Jr, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918.
48. Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 2002; 15:717-724.
49. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 2004; 15:524-537.
50. Sugiura T, Kobuchi S, Tsutsui H, et al. Preventive mechanisms of agmatine against ischemic acute kidney injury in rats. Eur J Pharmacol 2009; 603:108-113.
51. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995; 25:878-882.
52. Schlaich MP, Sobotka PA, Krum H, et al. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009; 54:1195-1201.
53. Kishi T, Hirooka Y. Central mechanisms of abnormal sympathoexcitation in chronic heart failure. Cardiol Res Pract 2012; 2012:847172.
54. Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012; 126:2976-2982.
55. Mulder J, Hokfelt T, Knuepfer MM, Kopp UC. Renal sensory and sympathetic nerves reinnervate the kidney in a similar time dependent fashion following renal denervation in rats. Am J Physiol Regul Integr Comp Physiol 2013; 304:R675-R682.
56. Sanchez-Reus MI, Gomez del Rio MA, Iglesias I, et al. Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats. Neuropharmacology 2007; 52:606-616.
57. De Ciuceis C, Amiri F, Brassard P, et al. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 2005; 25:2106-2113.
58. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38:399-403.
59. Ditting T, Tiegs G, Veelken R. Autonomous innervation in renal inflammatory disease: innocent bystander or active modulator J Mol Med (Berl) 2009; 87:865-870.
60. Linhart O, Obreja O, Kress M. The inflammatory mediators serotonin, prostaglandin E2 and bradykinin evoke calcium influx in rat sensory neurons. Neuroscience 2003; 118:69-74.
61. Mackie FE, Campbell DJ, Meyer TW. Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency. Kidney Int 2001; 59:1458-1465.
62. Zhu Y, Xie C, Wang DH. TRPV1-mediated diuresis and natriuresis induced by hypertonic saline perfusion of the renal pelvis. Am J Nephrol 2007; 27:530-537.
63. Ditting T, Freisinger W, Siegel K, et al. Tonic postganglionic sympathetic inhibition induced by afferent renal nerves Hypertension 2012; 59:467-476.
64. Feng N-H, Lee H-H, Shiang J-C, Ma M-C. Transient receptor potential vanilloid type 1 channels act as mechanoreceptors and cause substance P release and sensory activation in rat kidneys. Am J Physiol 2008; 294:F316-F325.
65. Xie C, Sachs JR, Wang DH. Interdependent regulation of afferent renal nerve activity and renal function: role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors. J Pharmacol Exp Ther 2008; 325:751-757.
66. Mizutani A, Okajima K, Murakami K, et al. Activation of sensory neurons reduces ischemia/reperfusion-induced acute renal injury in rats. Anesthesiology 2009; 110:361-369.
67. Hwang SW, Cho H, Kwak J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000; 97:6155-6160.
68. Shin J, Cho H, Hwang SW, et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci 2002; 99:10150-10155.
69. Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 2010; 90:513-557.
70. Lee JY, Walsh GM. Systemic and regional haemodynamic effects of renal denervation in spontaneously hypertensive rats. J Hypertens 1983; 1:381-386.
71. Krueger AD, Lee JY, Yang PC, et al. Selective vasodilation produced by renal denervation in adult spontaneously hypertensive rats. Hypertension 1986; 8:372-378.
72. Winternitz SR, Oparil S. Importance of the renal nerves in the pathogenesis of experimental hypertension. Hypertension 1982; 4:III108-III114.
73. Foss JD, Fink GD, Osborn JW. Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation. Hypertension 2013; 61:806-811.
74. Matsuoka H, Nishida H, Nomura G, et al. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994; 23:971-975.
75. Jacob F, Clark LA, Guzman PA, Osborn JW. Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol 2005; 289:H1519-1529.
76. Kandlikar SS, Fink GD. Splanchnic sympathetic nerves in the development of mild DOCA-salt hypertension. Am J Physiol Heart Circ Physiol 2011; 301:H1965-H1973.
77. Hausberg M, Grassi G. Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation J Hypertens 2007; 25:47-49.
78. Svarstad E, Myking O, Ofstad J, Iversen BM. Sympathetic nervous system overactivity in hypertensive patients with chronic renal failure: role of upright body position. Scand J Urol Nephrol 2001; 35:393-400.
79. Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment Kidney Int 2006; 69:967-973.
80. Gordon FJ, Mark AL. Mechanism of impaired baroreflex control in prehypertensive Dahl salt-sensitive rats. Circ Res 1984; 54:378-387.
81. Osborn JW. Hypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney. Clin Exp Pharmacol Physiol 2005; 32:384-393.
82. Osborn JW, Jacob F,Guzman P. A neural set point for the long-term control of arterial pressure: beyond the arterial baroreceptor reflex. Am J Physiol Regul Integr Comp Physiol 2005; 288:R846-855.
83. Kopp UC, Cicha MZ, Smith LA. Dietary sodium loading increases arterial pressure in afferent renal-denervated rats. Hypertension 2003; 42:968-973.
84. Wang DH, Wu W, Lookingland KJ. Degeneration of capsaicin-sensitive sensory nerves leads to increased salt sensitivity through enhancement of sympathoexcitatory response. Hypertension 2001; 37:440-443.
85. DiBona GF, Sawin LL. Effect of arterial baroreceptor denervation on sodium balance. Hypertension 2002; 40:547-551.
86. Ryuzaki M, Suzuki H, Kumagai K, et al. Renal nerves contribute to salt-induced hypertension in sinoaortic-denervated uninephrectomized rabbits. Am J Physiol 1992; 262:R733-R737.